CMAJ • August 14, 2007; 177 (4). doi:10.1503/cmaj.070186.
© 2007 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Résumé
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delaney, J. A.
Right arrow Articles by Suissa, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delaney, J. A., MSc
Right arrow Articles by Suissa, S., PhD
Related Collections
Right arrow Other gastroenterology
Right arrow Drugs: cardiovascular system
Right arrow Adverse drug reactions
Right arrow Français
Right arrowRelated Articles

Drug–drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding

Joseph A. Delaney, MSc, Lucie Opatrny, MD MSc, James M. Brophy, MD PhD and Samy Suissa, PhD

From the Division of Clinical Epidemiology (Delaney, Opatrny, Brophy, Suissa), the Department of Epidemiology, Biostatistics and Occupational Health (Delaney, Brophy, Suissa), and the Division of Internal Medicine (Opatrny), McGill University Health Centre, Montréal, Que.


View this table:
[in this window]
[in a new window]

 
Table 1.

 

View this table:
[in this window]
[in a new window]

 
Table 2.

 

Figure 114
View larger version (25K):
[in this window]
[in a new window]

 
Figure 1: Risk of gastrointestinal bleeding among patients in the United Kingdom General Practice Research Database who were prescribed acetylsalicylic acid (ASA), clopidogrel, warfarin or any type of non-ASA nonsteroidal anti-inflammatory drug (NSAID), either alone or in combination.